Review on Common Nanoparticles Use in Treatment of Parasitic Infection

Abstract

Parasites are organisms that depend on a host organism for their survival and obtain nutrients from them. They can either live on or inside the host. They have the potential to induce a diverse array of illnesses, spanning from malaria and trypanosomiasis to intestinal worms. Nanoparticles have the potential to revolutionize vaccine development for parasitic infections by improving antigen delivery, adjuvant effects, and overall vaccine efficacy. They provide creative answers to tackle the distinct difficulties presented by parasitic illnesses, getting us nearer to the objective of managing and eradicating these infections. Nonetheless, it is crucial to persist with the exploration and enhancement of nanoparticle-centered parasitic vaccines to guarantee their safety and efficacy. Additionally, it is imperative to navigate the regulatory channels for the authorization and dissemination of these vaccines. One of the most common nanoparticles used in parasitic disease treatment is liposomes. Liposomal drug delivery systems have shown their potential in improving drug solubility, stability, and targeted delivery to infected tissues. This has led to improved drug efficacy while minimizing side effects. Liposomal formulations have been successfully employed in the treatment of a range of parasitic diseases, such as leishmaniasis, malaria, and trypanosomiasis.